CohBar, Inc. (CWBR)
Largest Insider Buys in Sector
CWBR Stock Price History Chart
CWBR Stock Performance
About CohBar, Inc.
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived …
Insider Activity of CohBar, Inc.
Over the last 12 months, insiders at CohBar, Inc. have bought $0 and sold $0 worth of CohBar, Inc. stock.
On average, over the past 5 years, insiders at CohBar, Inc. have bought $292,764 and sold $111,905 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 13,889 shares for transaction amount of $10,000 was made by Barzilai Nir Yacov (director) on 2021‑11‑01.
List of Insider Buy and Sell Transactions, CohBar, Inc.
| 2021-11-01 | director | 13,889 0.0224% | $0.72 | $10,000 | -64.55% | |||
| 2021-11-01 | director | 20,000 0.0323% | $0.72 | $14,400 | -64.55% | |||
| 2021-10-28 | director | 167,000 0.258% | $0.58 | $96,175 | -55.45% | |||
| 2021-08-18 | Chief Executive Officer | 20,000 0.031% | $1.12 | $22,400 | -72.26% | |||
| 2021-08-11 | Sale | Chief Scientific Officer | 10,000 0.0194% | $2.01 | $20,100 | -80.28% | ||
| 2021-02-16 | Sale | Chief Scientific Officer | 10,000 0.016% | $1.90 | $19,000 | -40.67% | ||
| 2020-12-18 | director | 99,861 0.1478% | $1.22 | $121,830 | -8.51% | |||
| 2020-12-18 | CFO, Treasurer and Secretary | 7,490 0.0111% | $1.22 | $9,138 | -8.51% | |||
| 2020-09-03 | director | 11,000 0.0223% | $1.02 | $11,220 | +30.00% | |||
| 2020-09-02 | director | 6,000 0.0107% | $1.00 | $6,000 | +16.07% | |||
| 2020-08-28 | director | 8,196 0.0213% | $1.22 | $9,999 | +38.74% | |||
| 2020-08-28 | director | 8,169 0.0212% | $1.22 | $9,966 | +38.74% | |||
| 2020-08-28 | director | 204,918 0.5317% | $1.22 | $250,000 | +38.74% | |||
| 2020-08-28 | director | 20,000 0.0519% | $1.22 | $24,400 | +38.74% | |||
| 2020-08-06 | Sale | Chief Scientific Officer | 10,000 0.0182% | $1.90 | $19,000 | -36.39% | ||
| 2020-06-15 | Sale | Chief Scientific Officer | 10,000 0.023% | $2.41 | $24,100 | -43.39% | ||
| 2020-05-15 | Sale | Chief Scientific Officer | 10,000 0.0227% | $2.56 | $25,600 | -46.92% | ||
| 2020-04-22 | Sale | Chief Scientific Officer | 4,700 0.0105% | $1.90 | $8,930 | -27.04% | ||
| 2020-02-24 | Sale | CFO, Treasurer and Secretary | 5,000 0.0113% | $1.95 | $9,750 | -28.50% | ||
| 2020-02-21 | Sale | Chief Scientific Officer | 10,000 0.0221% | $1.90 | $19,000 | -28.14% |
Insider Historical Profitability
| Cohen Pinchas | 5449703 187.4728% | $0.61 | 1 | 0 | ||
| Barzilai Nir Yacov | director | 5075405 174.5968% | $0.61 | 2 | 0 | <0.0001% |
| FITZGERALD ALBION | director | 937863 32.263% | $0.61 | 6 | 0 | +38.74% |
| Stern Jon Leland | director | 674012 23.1864% | $0.61 | 4 | 0 | +15.12% |
| Petkevich Misha | director | 407609 14.022% | $0.61 | 4 | 0 | +7.34% |